***Meeting program subject to change.
Available Formats: = In Person
= On Demand
4:00–8:00 PM
Foyer International
6:00–8:00 PM
Foyer International
7:30–8:30 AM
Individual Hotel
8:00–8:30 AM
Londres Ballroom
8:00–5:00 PM
Londres Ballroom
Welcome and Keynote Address
8:30–9:30 AM
New York Ballroom
Maria D. Van Kerkhove, World Health Organization
Talk Title to be Announced
Why Should I Trust You? Podcast Introduction
9:30–9:40 AM
New York Ballroom
Predictive Modeling and Surveillance
9:40–11:45 AM
New York Ballroom
Bethan Purse, UK Centre for Ecology & Hydrology
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Yee-Sin LEO, National Centre for Infectious Diseases
Virus Surveillance and Predictive Modeling: Insights from Singapore's Public Health Interventions
Felicity Burt, University of The Free State
Diagnosis and Surveillance of Emerging Arboviruses in Africa
10:00–10:20 AM
Foyer International
11:45–12:45 PM
Zurich Ballroom
12:30–2:30 PM
Londres Ballroom
Symposia Spotlight 1: Transformative Strategies for Viral Discovery, Diagnosis, Prediction & Response
2:30–4:30 PM
New York Ballroom
Short Talks Chosen from Abstracts
4:30–5:00 PM
Foyer International
Pandemic Preparedness and Response Strategies
5:00–7:00 PM
New York Ballroom
Rick Arthur Bright, Bright Global Health
Detecting and Responding to Emerging Viral Infections
Pei-Yong Shi, GSK
GSK's Role in Strengthening Pandemic Preparedness
Anish Thekkumkara Surendran, Kerala One Health Centre for Nipah Research
Nipah Virus - Smart Policy Changes that can Help Quell Pandemic Risk
Short Talk(s) Chosen from Abstracts
7:30–8:30 AM
Individual Hotel
8:00–8:30 AM
Londres Ballroom
8:00–5:00 PM
Londres Ballroom
8:30–9:30 AM
New York Ballroom
Richard Hatchett, Coalition for Epidemic Preparedness Innovations, CEPI
The Future of Pandemic Preparedness
9:30–9:50 AM
Foyer International
9:50–11:50 AM
New York Ballroom
Ann M. Powers, Centers for Disease Control and Prevention
IXCHIQ FDA-Approved Chikungunya Vaccine
Andrea Marzi, NIAID, National Institutes of Health
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
George Warimwe, University of Oxford
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Kizzmekia S. Corbett-Helaire, Harvard T.H. Chan School of Public Health
Preparing for a Pandemic: Lessons from COVID Vaccines and Applications to Other Viral Diseases
11:50–12:50 PM
Zurich Ballroom
12:30–2:30 PM
Londres Ballroom
Panel Discussion: Scientific Challenges & Research Strategies for Pandemic Preparedness
3:00–4:30 PM
New York Ballroom
4:30–5:00 PM
Foyer International
5:00–7:00 PM
New York Ballroom
Laura M Walker, Moderna
Advancing Infectious Disease Treatment: The Role of mRNA Therapeutics
Suresh Mahalingam, Griffith University
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Alina Baum, Regeneron Pharmaceuticals
Filovirus Therapeutic Antibodies
Short Talk(s) Chosen from Abstracts
7:30–8:30 AM
Individual Hotel
8:30–11:30 AM
New York Ballroom
Martin Groschup, Friedrich-Loeffler-Institut
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Ian Brown, The Pirbright Institute
One Health Approach to Avian and Swine Influenza
Chee Wah Tan, National University of Singapore
Discovery of New Filoviruses/Other Viruses in Bats in Asia
Scott C. Weaver, University of Texas Medical Branch
Re-emerging Alphaviruses: Chikungunya and Western Equine Encephalitis
Short Talk(s) Chosen from Abstracts
9:30–9:50 AM
Foyer International
Lunch: Featuring Women in Pandemic Preparedness
11:30–12:30 PM
Zurich Ballroom
1:00–2:00 PM
New York Ballroom
Symposia Spotlight 2: Cutting-edge Countermeasures to Combat Emerging Viral Threats
2:30–4:30 PM
New York Ballroom
Short Talks Chosen from Abstracts
4:30–5:00 PM
Foyer International
Zoonoses 2 – Virus-Host Interactions
5:00–6:45 PM
New York Ballroom
Richard J. Webby, St. Jude Children's Research Hospital
An Unexpected Outbreak of H5N1 Influenza in Dairy Cattle
Geoffrey L. Smith, Shanghai Institute for Immunity and Infection, Chinese Academy of Sciences
Host Restriction of Monkeypox Virus and Viral Evasion Strategies
Christopher F. Basler, Icahn School of Medicine, Mt Sinai
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
New York Ballroom
